141 related articles for article (PubMed ID: 27904773)
1. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.
Shi R; Sun J; Sun Q; Zhang Q; Xia W; Dong G; Wang A; Jiang F; Xu L
Am J Cancer Res; 2016; 6(11):2587-2598. PubMed ID: 27904773
[TBL] [Abstract][Full Text] [Related]
2. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
[TBL] [Abstract][Full Text] [Related]
4.
Nie J; Lu L; Du C; Gao X
Transl Cancer Res; 2022 Oct; 11(10):3790-3802. PubMed ID: 36388033
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer.
Wang F; Zhang S; Wei Y; Chen H; Jiao Z; Li Y
Cancer Manag Res; 2019; 11():6775-6791. PubMed ID: 31413630
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
7. FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.
Liu X; Gao H; Zhang J; Xue D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910840
[TBL] [Abstract][Full Text] [Related]
8. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
[TBL] [Abstract][Full Text] [Related]
9. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
10. HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.
Yao Y; Luo J; Sun Q; Xu T; Sun S; Chen M; Lin X; Qian Q; Zhang Y; Cao L; Zhang P; Lin Y
Am J Cancer Res; 2017; 7(9):1820-1834. PubMed ID: 28979806
[TBL] [Abstract][Full Text] [Related]
11. Identification of the prognostic and therapeutic values of cyclin E1 (
Ullah MA; Farzana M; Islam MS; Moni R; Zohora US; Rahman MS
Heliyon; 2022 Sep; 8(9):e10367. PubMed ID: 36091953
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
14. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer and single-cell analysis reveals
Yu H; Chen Q; Wang Z; Qian X; Pan Y
Front Genet; 2022; 13():1009325. PubMed ID: 36568373
[No Abstract] [Full Text] [Related]
16. ZNF692 promotes proliferation and cell mobility in lung adenocarcinoma.
Zhang Q; Zheng X; Sun Q; Shi R; Wang J; Zhu B; Xu L; Zhang G; Ren B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1189-1196. PubMed ID: 28669730
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma.
Liao W; Liu W; Liu X; Yuan Q; Ou Y; Qi Y; Huang W; Wang Y; Huang J
Oncotarget; 2015 Sep; 6(27):24132-47. PubMed ID: 26125229
[TBL] [Abstract][Full Text] [Related]
18. Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.
Zhang J; Sun G; Mei X
Cancer Biomark; 2019; 26(3):367-373. PubMed ID: 31594212
[TBL] [Abstract][Full Text] [Related]
19. FAM83D activates the MEK/ERK signaling pathway and promotes cell proliferation in hepatocellular carcinoma.
Wang D; Han S; Peng R; Wang X; Yang XX; Yang RJ; Jiao CY; Ding D; Ji GW; Li XC
Biochem Biophys Res Commun; 2015 Mar; 458(2):313-20. PubMed ID: 25646692
[TBL] [Abstract][Full Text] [Related]
20. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]